CONGENITAL HEART SURGEONS' SOCIETY
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$1,132,013
Investments
70%
Cash & Equivalents
25%
Receivables (Non-Related)
3%
Other Assets
1%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Property, Plant, & Equipment (net)
0%
Liabilities in 2024 (Year End)
$78,557
Grants Payable
84%
Payables & Accruals
16%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$158,662
$283,397
+79%
Receivables (Non-Related)
$33,542
$36,590
+9%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$28,203
$6,679
-76%
Investments
$715,332
$793,365
+11%
Property, Plant, & Equipment (net)
-
-
-
Other Assets
$12,280
$11,982
-2%
Total Assets
$948,019
$1,132,013
+19%
Liabilities
2023
2024
Change
Payables & Accruals
$23,678
$12,557
-47%
Grants Payable
-
$66,000
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$23,678
$78,557
+232%
Net assets
2023
2024
Change
Restricted Net Assets
$898,714
$1,097,010
+22%
Unrestricted Net Assets
$25,627
-$43,554
-270%
Net assets
2023
2024
Change
Net assets
+$924,341
+$1,053,456
+14%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)